Skip to main content
GXAI
NASDAQ Technology

Gaxos.ai Q3: Revenue $2.81M, Loss Narrows to $0.08/Share, Cash Pile $13.3M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Gaming Stocks · Communication
Sentiment info
Neutral
Importance info
7
Price
$0.423
Mkt Cap
$4.717M
52W Low
$0.342
52W High
$2.63
52W Position info
24% above low
Off High info
84% below high
Rel. Volume info
20× avg
Market data snapshot near publication time

GXAI sits 24% above its 52-week low of $0.342 on elevated volume (20× avg).

Summary

Gaxos.ai's Q3 2026 10-Q shows revenue of $2.81 million and a narrowed net loss of $977,004 ($0.08 per share), backed by $12.7 million of working capital — but shares outstanding nearly doubled to 13.75 million on ATM sales and warrant exercises.


Key Events · Earnings and Guidance · GXAI

  • Q3 Revenue $2.81M, Loss Narrows

    Revenue of $2,814,527 versus $498,271 a year earlier; net loss fell to $977,004 from $1,140,873 and net loss per share improved to $0.08 from $0.14.

  • Nine-Month Operating Loss Widens

    Operating loss for the nine months grew to $5,526,299 from $3,689,144 as advertising and marketing rose to $8,523,776 from $1,552,215.

  • Balance Sheet: $12.7M Working Capital

    Cash of $1,895,334 plus short-term investments of $11,402,526 produced working capital of $12,693,960; management says this funds operations for the next twelve months against $4,538,025 of nine-month operating cash burn.

  • Share Count Nearly Doubles

    Shares outstanding rose to 13,752,288 from 7,123,453 at December 31, 2025, including 3,621,181 ATM shares and 3,007,654 shares issued on the August warrant exercise; 7,667,296 warrants remain outstanding at a $2.58 weighted average exercise price.


Analysis · GXAI · Technology

Revenue is real and growing fast, but the business mix has shifted: $1.96 million of the $2.81 million quarter came from RNK Health administrative services, with $855,907 from AI app subscriptions. The quarter's loss narrowed to $977,004 from $1,140,873, yet the nine-month operating loss widened to $5,526,299 from $3,689,144 because advertising and marketing ran at $8,523,776 versus $1,552,215 a year ago — the company is buying growth. Funding is not the near-term issue: $1,895,334 of cash plus $11,402,526 of short-term investments gives $12,693,960 of working capital, and management says that covers the next twelve months. The cost is dilution. Shares outstanding went from 7,123,453 at December 31, 2025 to 13,752,288, driven by 3,621,181 ATM shares and 3,007,654 shares from the August warrant inducement, and 7,667,296 warrants remain outstanding at a $2.58 weighted average strike — far above today's price, so they are unlikely to be exercised soon. Against a Nasdaq minimum-bid deficiency notice received October 1, 2026, the equity story now rests on whether subscription and health-services revenue can scale before the marketing spend has to be pulled back.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GXAI was trading at $0.42 on NASDAQ in the Technology sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $0.34 to $2.63. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GXAI - Latest Insights

GXAI
Nov 12, 2026, 4:06 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4801
Real-time Price: $0.4059 info
Change: -$0.0742 (-15%) info
Market Cap: $4.717M info
GXAI
Oct 01, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5309
Real-time Price: $0.4059 info
Change: -$0.125 (-24%) info
Market Cap: $4.717M info
GXAI
Aug 14, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.838
Real-time Price: $0.4059 info
Change: -$0.4321 (-52%) info
Market Cap: $4.717M info
GXAI
Aug 14, 2026, 4:19 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.838
Real-time Price: $0.4059 info
Change: -$0.4321 (-52%) info
Market Cap: $4.717M info
GXAI
Aug 14, 2026, 4:19 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.838
Real-time Price: $0.4059 info
Change: -$0.4321 (-52%) info
Market Cap: $4.717M info